Penicillins Flashcards

(37 cards)

1
Q

β-lactam Mechanism of Action

A

watch video:

https://www.youtube.com/watch?v=qBdYnRhdWcQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Penicillin Binding Proteins (PBPs)

A

• Enzymes which act as catalysts in synthesis of the
peptidoglycan cell wall

• Many different types and amounts of PBPs in different
bacteria (related bacteria similar)

• Numbered by decreasing size in each different type of
bacteria.

  • Therefore: PBP1 in S. aureus ≠ PBP1 in E. coli
  • Different PBPs may have different effects on cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Effects of E. coli PBPs

A

• PBP 1a, 1b cause cell elongation
(inhibition causes rapid cell lysis)

• PBP 2 determine bacterial shape
(inhibition → stable round forms which grow for several
generations then lyse)

• PBP 3 involved in cell division
(inhibition → filamentous forms which grow for 5-6
generations then become deformed and die)

• PBP 4, 5, 6 of little consequence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Resistance to β-Lactams

A
  • Production of β-lactamases
  • Reduced affinity of PBP for β-lactam antibacterials
  • Impermeability of cell membrane
  • Efflux
  • Organisms lacking a cell wall, (e.g., Mycoplasma)
  • Tolerance (↓ activity of autolysins)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classes of Penicillin

Antibacterials

A

Natural Penicillins
Penicillin G, Penicillin V

Penicillinase-resistant Penicillins
Cloxacillin

Aminopenicillins
Ampicillin, Amoxicillin

Carboxypenicillins
(Ticarcillin → no longer available in Canada)

Ureidopenicillins
Piperacillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Spectrum of Activity of

Penicillin G, Penicillin V

A

• Most active against non-β-lactamase producing
Gram-positive bacteria, but we have seen increasing
resistance

• Anaerobes (Gram-positive)

  • However, there are β-lactamase producing strains
  • B. fragilis is Gram-negative and not covered

• Selected Gram-negative cocci
- e.g., Neisseria meningitidis

penV more resistant to stomach acid especially with potassium salt

penG more orally
Narrow spetrum
Not for empiric treatment
Known pathogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Spectrum of Activity of Penicillin G

A

see slide 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Resistance to Penicillin

Staphylococcus aureus

A

• most now produce β-lactamases

• some have altered PBPs (MRSA)
- PBP2a are produced that can take over role of PBPs
bound by penicillins - results in resistance to almost
all β-lactams
- Incidence MRSA Edmonton
* Dynalife 2008 (19%), 2019 (25%)
* UAH 2008 (28%), 2019 (23%)

• in some areas in US > 50% of S. aureus are MRSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Resistance to Penicillin

Staphylococcus epidermidis (CoNS)

A

• Most produce β-lactamase

• Many have changes in PBPs resulting in resistance to
almost all β-lactams (MRSE)

• MRSE Edmonton - ~50-70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Resistance to Penicillin

Streptococcus pyogenes (Group A Streptococci)

A

• All susceptible!

NO REPORTS OF RESISTANCE
Some reports of reduced suscept

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Resistance to Penicillin

Viridans Group of Streptococci

A

• resistance due to β-lactamase and transfer of
resistance gene PBP2b from S. pneumoniae
- (penicillin resistant UAH 20% 2012 ; 44% 2019)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Resistance to Penicillin

Streptococcus agalactiae (Group B Streptococci)

A

• Canada - All susceptible

• 4 clones with reduced susceptibility to β-lactams
reported due to point mutation
(AAC Aug 2008, pg 2915-2918)

• (resistant strain reported in cattle - altered PBP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Resistance to Penicillin

Streptococcus pneumoniae

A

• S. Africa, Spain (50%), U.S.A. (30 - 50%),
Canada (~20%)
- altered PBPs

• Dynalife Community (% non-susceptible)

  • 2006 - 11% non-susceptible
  • 2019 - 9% non-susceptible
  • 2019 - 12% (Meningeal*)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Resistance to Penicillin

Enterococci

A

• β-lactamase production, altered PBPs rare with E.
faecalis, but more common with E. faecium

• Enterococcus faecalis
- 100% Susceptible to ampicillin/amoxicillin (2019
Edmonton community)
- 99% Susceptible to ampicillin/amoxicillin (2019 UAH)

• Enterococcus faecium
- 36% susceptible to amp/amox (2019 Edmonton
Community)
- 8% susceptible to amp/amox (2019 UAH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Resistance to Penicillin

N. gonorrhoeae

A
  • β-lactamase production
  • decreased affinity of PBPs
  • Can no longer use penicillin empirically for gonorrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Resistance to Penicillin

Enterobacterales

A

Enterobacterales are intrinsically resistant to penicillin due to:

  • β-lactamase production
  • reduced affinity for PBP
  • cell wall impermeability
17
Q

Summary Penicillin Resistance

18
Q

Penicillinase-Resistant
Semi-synthetic Penicillins

cloxacillin role?

A

• Bulky side chain provides β-lactamase resistance with
staphylococci (protects site on β-lactam ring from
bindingto β-lactamase breaking open the β-lactam
ring)

• ↑ activity against β-lactamase producing
staphylococci, but not methicillin-resistant
staphylococci (MRSA, MRSE)

• Cloxacillin has a limited spectrum
- Penicillin and ampicillin are more active against
Streptococci
- Cloxacillin usually only used to treat skin infections
with S. aureus and S. pyogenes
- inactive against Enterococci, Listeria, and Gram
negatives

19
Q

Aminopenicillins

A
  • Amino group added to side chain
  • ↑ entry into cell, ↑ affinity for PBP

• ↑ spectrum against “easily killed” Gram-negatives
(H. influenzae, E. coli, Proteus mirabilis)

• But resistance developing due to β-lactamase
production
- N. gonorrheae, H. influenzae, E. coli, P. mirabilis

• Some resistance due to changes in PBPs
- e.g., some H. influenzae (~5%) have changed PBPs

20
Q

Comparison of

Ampicillin/Amoxicillin Spectrum to Penicillin G

A

• more active against

  • S. pneumoniae (97% Susceptible – Dynalife Dx 2019)
  • Enterococcus
  • L. monocytogenes
  • ↑ Gram-negative effect, but now many resistant
  • % Susceptible Dynalife (Community) 2019
    • H. influenzae 76%
    • E. coli 56%
    • Proteus mirabilis 69%
21
Q

Ampicillin

A
  • Available IV, IM, PO
  • PO → 30-60% absorbed, acid labile, (diarrhea)

• Well-distributed → CSF*, pleural, joint, and peritoneal
fluids

• ↑ incidence skin rash

22
Q

Amoxicillin

A

• Only available PO (unless combined with
clavulanic acid – IV formulation available)

• Relative to ampicillin

  • ↑ resistance to gastric acid (can take with food)
  • ↑ absorption (2 - 2.5 x blood levels of ampicillin)
  • less diarrhea
23
Q

Clavulanic Acid

Inhibitor?

A
  • β-lactamase Inhibitor
  • irreversibly binds to β-lactamase (suicide inhibitor)
  • combined with amoxicillin (Clavulin®, Augmentin®)

• inhibits plasmid-mediated β-lactamases of
Staphylococci, H. influenzae, M. catarrhalis, some
Enterobacterales (Enterobacteriaceae), B. fragilis

24
Q

Clavulanic Acid

Characteristics

A
  • well absorbed orally
  • t 1/2 1 hour (similar to amoxicillin)
  • 25 - 40% excreted unchanged in urine
  • excretion not inhibited by probenecid
  • few side effects on its own - diarrhea / nausea
    • To prevent this:
      • adult oral dose clavulanic limited to 125 mg/dose
        (i. e., BID-TID)
      • Maximum dose children 10 mg/kg/day
      • does not cross into the CSF well
25
Amoxicillin / Clavulanic Acid
Expanded spectrum includes: • β-lactamase producing Staphylococci (not MRSA, MRSE), • Haemophilus influenzae, Moraxella catarrhalis • Many Enterobacterales (E.coli, Klebsiella pneumoniae, Proteus mirabilis) • Not AmpC β-lactamase producing Enterobacterales or Pseudomonas • Bacteroides spp., including B. fragilis
26
Antipseudomonal Penicillins
• Carboxypenicillins (Ticarcillin) ??? (please check, this is crossed - out in the slide) • Ureidopenicillins (Piperacillin)
27
Ureidopenicillins Piperacillin / Tazobactam
• Spectrum of activity includes - β-lactamase producing Staphylococci (not MRSA) - Streptococci and Enterococci (comparable to ampicillin/amoxicillin) - Good activity against Pseudomonas aeruginosa * UAH – 84% Susceptible (2019) * Edmonton Community – 94% Susceptible (2019) - H. influenzae, M. catarrhalis - Many Enterobacterales, including ESBL* producing E.coli, Klebsiella - Bacteroides fragilis ``` • Does not improve activity against AmpC producing “SPICE A” organisms - Serratia, Providencia, Indole-positive Proteus (P. vulgaris), Citrobacter, Enterobacter, Acinetobacter ```
28
Distribution of Penicillins
• well distributed to most areas • in presence of inflammation - good levels middle ear, pleural, peritoneal, and synovial fluids and adequate CSF levels • in absence of inflammation - levels minimal in CSF, eye, brain, prostate - in CNS – inflammation permits entry and alters anion pump that removes penicillins from CNS (as in meningitis) • Protein binding variable - 17% ampicillin - 94% cloxacillin
29
Metabolism / Excretion of Penicillins
• Most excreted intact by kidneys by glomerular filtration and renal tubular secretion • Most have high levels in urine, even with moderate renal failure - but once CrCl < 10 mL/min, urine levels not > blood levels • minor degree metabolism in all ``` • some degree of biliary excretion in all, particularly with antistaphylococcal penicillins (e.g., cloxacillin) ``` • t 1/2 vary 30 - 72 min
30
Various Penicillins comparison of % absorbed, effect of food, protein binding %, % metabolized, t 1/2 h CrCl > 90, t 1/2 h CrCl < 10 which ones have asborbtion affected by food and should be taken on empty stomach?
see slide 37 pen G, Cloxaxillin, ampicillin Pen V better abs on empty stomach but not as important
31
Dosage Adjustments
• ↓ renal function elderly, neonates, and those with compromised renal function • CrCl < 10 ml/min - slight reduction in most - No change for cloxacillin (hepatic and biliary compensation)
32
Adverse Effects
• Main adverse effects of penicillins are hypersensitivity reactions ranging from rash to anaphylaxis • 1-10% of patients receiving penicillin will have an adverse reaction, including allergy • Estimated as many as 1/2 of all allergic reactions occurring in hospital are due to β-lactam antibacterials ( Bugs & Drugs ) • 0.01-0.02% treated with parenteral penicillin have life threatening anaphylactic reactions, with a fatality rate of 0.0015-0.02% ( Bugs & Drugs )
33
Adverse Effects – CNS Toxicity
``` • Myoclonic Seizures (Rare) - More likely if penicillin given - Large Doses - (usual adult dose penicillin ranges from 500,000U bid – 2 million units q2h) ``` • Or penicillin given in patients with renal failure without dosage adjustment - (direct application to cortex → seizures) - (instillation into ventricles at the time of shunt placement no seizures)
34
Adverse Effects – Renal
• Interstitial Nephritis <1% (Type III Reaction) - Rare - ranges from allergic angiitis to interstitial nephritis - fever, rash, eosinophilia, proteinuria, hematuria - may progress to anuria and renal failure - Usually only after long term, high dose therapy - most common with methicillin, but may occur with any penicillin - most return to normal after discontinue drug
35
Adverse Effects – Hematologic
• Neutropenia (1- 4%) (Type II reaction) - may occur with all penicillins - more often with large doses - WBC count returns to normal after discontinue drug - lower dose may sometimes be tolerated - In patients with previous hemolytic reaction to pencillin, re-administration of pencillin may result in a rapid hemolytic response resulting in death • Coombs positive hemolytic anemia - Rare - Type II reaction * penicillin binds to RBC * antibody forms * Complement is fixed and Membrane Attack Complex (MAC) forms with destruction of RBC
36
Adverse Effects – Gastrointestinal
• Hepatic - ↑ alkaline phosphatase, ↑ AST - most often in past with oxacillin, carbenicillin (which we don’t use clinically now) - hepatic injury uncommon (1- 4%) - enzymes return to normal when discontinue drug
37
Drug Interactions
• Allopurinol and Ampicillin - increased incidence of rash ( up to 14 - 22.4%) * Oral Contraceptives * Aminoglycosides (synergy; in vitro inactivation) ``` Prolong half life of Avoid giving together Separate by hours Ynergistic Inactivate each other in vitro ``` • Probenecid (reduced excretion/increased levels) Prolonged dosing intervals, purposely given with beta lactams